Godavari Biorefineries last traded at ₹224.40 (2026-10-13). Over the past month the stock moved -5.5%, three months the stock moved -20.9%, year the stock moved -23.2%. Its closing range over 52 weeks is ₹220.00 – ₹333.00, with the latest close 32.6% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]
Business Overview:[1][2] a) GBL is a part of the Somaiya group which holds 63.31% equity stake in the company through entities. b) It has an Integrated Bio-refinery across value chain viz. Sugar, Branded Sugar, Ethanol, Bio Based Chemicals & Power c) It has India’s first bio-based Ethyl Vinyl Ether (EVE) manufacturing facility in India d) Company is the largest Manufacturer of MPO in India in terms of installed capacity e) It is one of only 2 Manufacturers of natural 1,3 Butylene Glycol (BG) globally f) The company has an in-house retail brand Jivana for sale of sugar, turmeric, and salt in Rajasthan Maharashtra, Karnataka, and Gujarat.
In the latest quarter (Jun 2026), Godavari Biorefineries reported sales of ₹558.00 crore (+4.7%) and net profit of ₹-19.00 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 558.00 | 1.00 | 0.10 | -19.00 | -3.78 |
| Mar 2026 | 564.00 | 86.00 | 15.00 | 53.00 | 10.33 |
| Dec 2025 | 460.00 | 43.00 | 9.00 | 8.00 | 1.61 |
| Sep 2025 | 431.00 | -8.00 | -1.80 | -42.00 | -8.13 |
| Jun 2025 | 533.00 | 6.00 | 1.10 | -16.00 | -3.13 |
| Mar 2025 | 580.00 | 112.00 | 19.00 | 72.00 | 14.06 |
| Dec 2024 | 447.00 | 36.00 | 8.00 | 6.00 | 1.13 |
| Sep 2024 | 321.00 | -33.00 | -10.00 | -75.00 | -17.88 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +34.3% | +12.3% | -5.7% | +1.9% | +34.3% | +2.9% | -2.8% | +4.7% |
| Operating profit growth | – | -20.0% | -1.8% | – | – | +19.4% | -23.2% | -83.3% |
| Net profit growth | – | -84.2% | +10.8% | – | – | +33.3% | -26.4% | – |
| EPS growth | – | -87.7% | -9.5% | – | – | +42.5% | -26.5% | – |
| OPM % | -10.0% | 8.0% | 19.0% | 1.1% | -1.8% | 9.0% | 15.0% | 0.1% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Godavari Biorefineries reported sales of ₹1,988.00 crore (+6.3%) and net profit of ₹4.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 1,988 | 127.00 | 6.00 | 4.00 | 0.69 |
| Mar 2025 | 1,870 | 104.00 | 6.00 | -23.00 | -4.57 |
| Mar 2024 | 1,687 | 134.00 | 8.00 | 12.00 | 2.93 |
| Mar 2023 | 2,015 | 147.00 | 7.00 | 20.00 | 4.68 |
| Mar 2022 | 1,702 | 135.00 | 8.00 | 19.00 | 4.64 |
| Mar 2021 | 1,538 | 158.00 | 10.00 | 27.00 | 6.47 |
| Mar 2020 | 1,459 | 103.00 | 7.00 | 4.00 | 0.97 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | +5.4% | +10.7% | +18.4% | -16.3% | +10.8% | +6.3% |
| Operating profit growth | +53.4% | -14.6% | +8.9% | -8.8% | -22.4% | +22.1% |
| Net profit growth | +575.0% | -29.6% | +5.3% | -40.0% | -291.7% | – |
| EPS growth | +567.0% | -28.3% | +0.9% | -37.4% | -256.0% | – |
| OPM % | 10.0% | 8.0% | 7.0% | 8.0% | 6.0% | 6.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Godavari Biorefineries.
Get Free AI Stock Analysis FREE →Godavari Biorefineries jumps nearly 10% after Chinese patent grant for antiviral compound - BusinessLine
Godavari Biorefineries receives Chinese patent for use of compounds for treatment of viral infection - Business Standard
Godavari Biorefineries jumps on bagging Chinese patent for antiviral compound - Business Standard
Godavari Biorefineries share price rallies 13% after Chinese patent grant | Do you own?
Godavari Biorefineries share price rallies 13% after Chinese patent grant | Do you own?
Godavari Biorefineries receives Chinese patent for use of compounds for treatment of viral infection - Business Standard
Godavari Biorefineries jumps nearly 10% after Chinese patent grant for antiviral compound - BusinessLine
Godavari Biorefineries jumps on bagging Chinese patent for antiviral compound - Business Standard
Godavari Biorefineries zooms on securing Japanese patent for treatment of cancer
Godavari Biorefineries Secures Japanese Patent for Cancer Treatment Compounds; Shares Up Over 6%
Godavari Biorefineries shares were last quoted at ₹224.40 (+1.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Godavari Biorefineries has a price-to-earnings (P/E) ratio of 5,927.50 and a price-to-book (P/B) ratio of 1.58. The industry P/E is 43.03.
The 52-week high of Godavari Biorefineries is ₹353.50 and the 52-week low is ₹224.00.
The market capitalisation of Godavari Biorefineries is about ₹1,213.38 crore.
In the latest quarter (Jun 2026), Godavari Biorefineries reported sales of ₹558.00 crore (+4.7%) and net profit of ₹-19.00 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Godavari Biorefineries has a 3-year ROE of 1.00%, 3-year profit growth of 18.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 63.31% of Godavari Biorefineries.
Godavari Biorefineries belongs to the Diversified sector.